Monoclonal antibody to thyroid transcription factor-1: Production, characterization, and usefulness in tumor diagnosis

Hybridoma

Volumn 15, Issue 1, 1996, Pages 49-53

  Holzinger, Andreas ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; COLON CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG ADENOCARCINOMA; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; REPRODUCIBILITY; TUMOR DIAGNOSIS;

EID: 0029875197     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1996.15.49     Document Type: Article

References (4)

1. Guazzi S, Price M, Felice MD, Damante G, Mattei M, and DiLauro R: Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J 1990;9: 3631-3639.
2. Lazzaro D, Price M, Felice MD, and Dilauro R: The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991;113:1093-1104.
3. Bohinski RJ, Dilauro R, and Whitsett JA: The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis. Mol Cell Biol 1994;14:5671-5681.
4. Bejarano P, Baughman R, Biddinger P, Fenoglio-Preiser C, AlKhafaji B, Miller M, and Whitset J: Immunohistochemical expression of surfactant proteins A and B (SP-A, SP-B) and TTF-1 to distinguish lung and breast carcinomas. Mod Pathol 1995;8:148A.